FR2425243B1 - - Google Patents

Info

Publication number
FR2425243B1
FR2425243B1 FR7911494A FR7911494A FR2425243B1 FR 2425243 B1 FR2425243 B1 FR 2425243B1 FR 7911494 A FR7911494 A FR 7911494A FR 7911494 A FR7911494 A FR 7911494A FR 2425243 B1 FR2425243 B1 FR 2425243B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7911494A
Other versions
FR2425243A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nelson Research and Development Co
Original Assignee
Nelson Research and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/903,586 external-priority patent/US4188394A/en
Priority claimed from US05/904,586 external-priority patent/US4190673A/en
Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co
Publication of FR2425243A1 publication Critical patent/FR2425243A1/fr
Application granted granted Critical
Publication of FR2425243B1 publication Critical patent/FR2425243B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7911494A 1978-05-08 1979-05-07 Composition ophtalmique et methode d'utilisation Granted FR2425243A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/903,586 US4188394A (en) 1978-05-08 1978-05-08 Ophthalmic composition and method of use
US05/904,586 US4190673A (en) 1978-05-10 1978-05-10 Colchicine ophthalmic composition and method of use

Publications (2)

Publication Number Publication Date
FR2425243A1 FR2425243A1 (fr) 1979-12-07
FR2425243B1 true FR2425243B1 (fr) 1984-07-20

Family

ID=27129366

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7911494A Granted FR2425243A1 (fr) 1978-05-08 1979-05-07 Composition ophtalmique et methode d'utilisation

Country Status (7)

Country Link
AU (1) AU527129B2 (fr)
CA (1) CA1139668A (fr)
DE (1) DE2918264A1 (fr)
FR (1) FR2425243A1 (fr)
GB (1) GB2020180B (fr)
IE (1) IE48222B1 (fr)
IT (1) IT1113376B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4918165A (en) * 1987-07-16 1990-04-17 Ophthalmic Research Corporation Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine

Also Published As

Publication number Publication date
GB2020180A (en) 1979-11-14
DE2918264A1 (de) 1979-11-15
AU527129B2 (en) 1983-02-17
CA1139668A (fr) 1983-01-18
GB2020180B (en) 1982-08-25
IE48222B1 (en) 1984-10-31
FR2425243A1 (fr) 1979-12-07
AU4665179A (en) 1979-11-15
IT7922443A0 (it) 1979-05-08
IT1113376B (it) 1986-01-20
IE790908L (en) 1979-11-08

Similar Documents

Publication Publication Date Title
FR2414330B1 (fr)
FR2416399B3 (fr)
FR2416954B1 (fr)
FR2425243B1 (fr)
FR2416747B1 (fr)
FR2416341B1 (fr)
FR2417094B3 (fr)
DE2827856C2 (fr)
FR2416953B1 (fr)
FR2414864B1 (fr)
AU3898778A (fr)
FR2416498B1 (fr)
FR2415628B1 (fr)
AU73950S (fr)
BG26007A1 (fr)
BG25971A1 (fr)
BG26022A1 (fr)
BG26017A1 (fr)
BG26015A1 (fr)
BG26014A1 (fr)
BG26013A1 (fr)
BG26012A1 (fr)
BG26009A1 (fr)
BG26008A1 (fr)
BG25954A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse